Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Stock indices serve as market barometers, benchmarks, and investment guides. Learn how they inform decisions and performance tracking.
17,462 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Evercore ISI launches SpaceX coverage with an Outperform rating and a $230 target, fueling a new wall street spacex b...
In a world of rapid leadership shifts, Warren Buffett just reaffirmed his stance on Apple as a core holding. This art...
Apple and Nvidia sit at the pinnacle of market caps, but they play very different roles in investors’ portfolios. Thi...
As Advansix positions itself in a volatile chemical market, understanding advansix (asix) 2025 earnings becomes essen...
As quantum tech evolves, investors wonder where will rigetti computing end up by 2030. This article breaks down miles...
Looking at how applied optoelectronics (aaoi) earnings shape the stock story? This guide breaks down what to watch in...
CrowdStrike is set to report Q4 results after the close, with analysts predicting a beat on non-GAAP earnings and rev...
When market swings unsettle investors, reliable dividend stocks double right can stabilize returns. Here are two prov...
Disney faces a cash flow decline even as streaming profitability edges higher. The market-wide tug-of-war keeps DIS a...
A new collaboration between Uber and Amazon's Zoox signals more than tech sharing. This alliance could redefine the e...
MicroStrategy stock rose about 5% as Bitcoin momentum boosted interest in its sizable BTC treasury, underscoring the ...